1. DS-7300a, a novel B7-H3-targeting antibody-drug conjugate with a novel DNA topoisomerase I inhibitor DXd, exhibits potent anti-tumor effects in nonclinical models. (October 2020) Authors: Yamato, M.; Hasegawa, J.; Hattori, C.; Maejima, T.; Shibutani, T.; Deguchi, T.; Izumi, N.; Watanabe, A.; Nishiya, Y.; Nakada, T.; Abe, Y.; Agatsuma, T. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-1523: Predictive factors of over Grade 2 radiation pneumonitis for advanced non-small cell lung cancer. (November 2020) Authors: Muraki, K.; Ogo, E.; Suefuji, H.; Eto, H.; Tsuji, C.; Hattori, C.; Miyata, Y.; Abe, T. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S823 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PV-0190: The analysis of prostate cancer with median lobe hyperplasia treated I-125 brachytherapy. (May 2017) Authors: Muraki, K.; Suefuji, H.; Ogo, E.; Eto, H.; Tsuji, C.; Hattori, C.; Miyata, Y.; Himuro, H.; Abe, T.; Hayashi, S.; Chikui, K.; Nakiri, M.; Igawa, T. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗